Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001387131-23-007637
Filing Date
2023-06-16
Accepted
2023-06-16 17:12:07
Documents
5
Effectiveness Date
2023-06-16

Document Format Files

Seq Description Document Type Size
1 INITIAL REGISTRATION STATEMENT tnxp-s8_061623.htm S-8 60603
2 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP ex5-01.htm EX-5.01 10594
3 CONSENT OF EISNERAMPER LLP ex23-01.htm EX-23.01 3804
4 FILING FEE TABLE ex107.htm EX-FILING FEES 7885
5 GRAPHIC brownsteinlogo.jpg GRAPHIC 6158
  Complete submission text file 0001387131-23-007637.txt   92609
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-272746 | Film No.: 231022220
SIC: 2834 Pharmaceutical Preparations